Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database
- PMID: 28425170
- DOI: 10.1002/art.40091
Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database
Abstract
Objective: To examine trends in rheumatoid arthritis (RA) as an underlying cause of death (UCD) in 31 countries across the world from 1987 to 2011.
Methods: Data on mortality and population were collected from the World Health Organization mortality database and from the United Nations Population Prospects database. Age-standardized mortality rates (ASMRs) were calculated by means of direct standardization. We applied joinpoint regression analysis to identify trends. Between-country disparities were examined using between-country variance and the Gini coefficient. Due to low numbers of deaths, we smoothed the ASMRs using a 3-year moving average. Changes in the number of RA deaths between 1987 and 2011 were decomposed using 2 counterfactual scenarios.
Results: The absolute number of deaths with RA registered as the UCD decreased from 9,281 (0.12% of all-cause deaths) in 1987 to 8,428 (0.09% of all-cause deaths) in 2011. The mean ASMR decreased from 7.1 million person-years in 1987-1989 to 3.7 million person-years in 2009-2011 (48.2% reduction). A reduction of ≥25% in the ASMR occurred in 21 countries, while a corresponding increase was observed in 3 countries. There was a persistent reduction in RA mortality, and on average, the ASMR declined by 3.0% per year. The absolute and relative between-country disparities decreased during the study period.
Conclusion: The rates of mortality attributable to RA have declined globally. However, we observed substantial between-country disparities in RA mortality, although these disparities decreased over time. Population aging combined with a decline in RA mortality may lead to an increase in the economic burden of disease that should be taken into consideration in policy-making.
© 2017, American College of Rheumatology.
Comment in
-
Editorial: Is Rheumatoid Arthritis a Mortal Disease?Arthritis Rheumatol. 2017 Aug;69(8):1509-1511. doi: 10.1002/art.40145. Epub 2017 Jul 13. Arthritis Rheumatol. 2017. PMID: 28666077 No abstract available.
Similar articles
-
Musculoskeletal disorders as underlying cause of death in 58 countries, 1986-2011: trend analysis of WHO mortality database.BMC Musculoskelet Disord. 2017 Feb 2;18(1):62. doi: 10.1186/s12891-017-1428-1. BMC Musculoskelet Disord. 2017. PMID: 28153007 Free PMC article.
-
Mortality from Musculoskeletal Disorders Including Rheumatoid Arthritis in Southern Sweden: A Multiple-cause-of-death Analysis, 1998-2014.J Rheumatol. 2017 May;44(5):571-579. doi: 10.3899/jrheum.161219. Epub 2017 Mar 1. J Rheumatol. 2017. PMID: 28250137
-
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.Diabetologia. 2018 Jul;61(7):1592-1602. doi: 10.1007/s00125-018-4626-y. Epub 2018 May 1. Diabetologia. 2018. PMID: 29717336 Free PMC article.
-
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017.Rheumatol Int. 2021 Dec;41(12):2225-2231. doi: 10.1007/s00296-021-05013-z. Epub 2021 Oct 5. Rheumatol Int. 2021. PMID: 34609597
-
Mortality in rheumatoid arthritis: 2008 update.Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S35-61. Clin Exp Rheumatol. 2008. PMID: 19026144 Review.
Cited by
-
Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response.Biomed Res Int. 2019 May 7;2019:3494937. doi: 10.1155/2019/3494937. eCollection 2019. Biomed Res Int. 2019. PMID: 31205940 Free PMC article. Review.
-
In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis.Arthritis Res Ther. 2019 Mar 12;21(1):72. doi: 10.1186/s13075-019-1852-8. Arthritis Res Ther. 2019. PMID: 30867044 Free PMC article.
-
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.Ann Rheum Dis. 2019 Oct;78(10):1305-1319. doi: 10.1136/annrheumdis-2019-215164. Epub 2019 Jul 26. Ann Rheum Dis. 2019. PMID: 31350269 Free PMC article. Clinical Trial.
-
Rheumatoid arthritis: The benefits of early treatment after decades.Nat Rev Rheumatol. 2017 Aug;13(8):458-459. doi: 10.1038/nrrheum.2017.104. Epub 2017 Jun 29. Nat Rev Rheumatol. 2017. PMID: 28660916 No abstract available.
-
The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2020 Oct 30;7:596007. doi: 10.3389/fmed.2020.596007. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33195358 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical